Investing Profile

Jim Tananbaum

Foresite Capital Managing Partner

Photo of Jim Tananbaum, Managing Partner at Foresite Capital
cb
Foresite Capital Managing Partner
9
CompanyStageDateRound SizeTotal Raised
Series AMay 2018
Seed RoundJan 2018$12.3M
$12.3M
Series EJan 2018$58M
$89.6M
Series ASep 2017$55M
$55M
Series BMar 2015$80M
$80M
Series BMay 2014$7M
Series BMar 2012$28M
$35M
Series DApr 2014$200M
$558M
Series CJul 2013$20M
$41.5M
Founder and CEO Foresite Capital Management2010 - Present
Co-Founder and Managing Director PVP2 & PVP3 Prospect Venture Partners2001 - 2010
Co-Founder and Chief Executive Officer Theravance (THRX)1997 - 2000
Partner Sierra Ventures1993 - 1997
Co-Founder and CEO GelTex (acquired by Genzyme for $1.6 B)1991 - 1992
Harvard Business School mba
Harvard Medical School Doctor of Medicine (MD)
Massachusetts Institute of Technology Master of Science (M.S.) HST - information theory
Yale University BS BSEE, Math, computer science